Overview

Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks

Status:
Terminated
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to demonstrate that TI® Inhalation Powder combined with Lantus® is as effective as Humalog® combined with Lantus® on HbA1c.
Phase:
Phase 3
Details
Lead Sponsor:
Mannkind Corporation
Treatments:
Insulin
Insulin Glargine
Insulin Lispro
Insulin, Globin Zinc